Printer-friendly versionSend to friend

Scientific Advisory Board

The Institute's leadership is guided by a scientific advisory board comprised of distinguished scientists from business & academic institutions.

• Pedro Cuatrecasas, MD (Co-Chair) - Retired President, Parke Davis/Warner Lambert Pharmaceutical Research Division, San Diego
• Peter Agre, MD - Vice-Chancellor for Science and Technology, Duke University; 2003 Nobel Laureate in Chemistry
• Ronnie Cresswell, DSc - Retired Senior Vice President, Warner Lambert Co.; Retired Chairman, Parke-Davis Pharmaceutical Research, Ann Arbor
• Jennifer A Doudna, PhD - Howard Hughes Medical Institute Investigator, Professor of Molecular and Cell Biology, University of California, Berkeley
• Helen Hobbs, MD - Director, Eugene McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center, Dallas
• C. Ronald Kahn, MD - Director, Joslin Diabetes Center; Professor of Medicine, Harvard Medical School, Boston, Massachusetts
• Laura Kiessling, PhD - Professor of Biochemistry, University of Wisconsin, Madison
• Jeffrey Leiden, MD, PhD - President and Cheif Executive Officer, Vertex Pharmaceuticals, Cambridge, Massachusetts
• Frank McCormick, MD - Director of the Comprehensive Cancer Center & Cancer Research Institute, University of California, San Francisco
• Paul M. Meister (Co-Chair) - Chief Executive Officer and Co-Founder of Liberty Lane Partners
• Stuart Orkin, MD - Chair, Department of Pediatric Oncology, Dana Farber Cancer Institute, Boston, Massachusetts; David G. Nathan Professor of Pediatrics, Harvard Medical School
• Craig Parker - Vice President of Strategy & Corporate Development, Human Genome Sciences, Inc., Rockville, Maryland
• Randy W. Schekman, PhD - Howard Hughes Medical Institute Investigator, Professor of Molecular and Cell Biology, University of California, Berkeley
• David Walt, PhD - Robinson Professor of Chemistry, Tufts University, Founder and Director of Illumina, Inc.